Comparison of IPX066, a novel investigational carbidopa-levodopa (CD-LD) extended-release formulation, and CD-LD-entacapone (CLE) in advanced Parkinson's disease (ASCEND-PD trial)
MOVEMENT DISORDERS（2012）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined